Cargando…

Based on network pharmacology method to discovered the targets and therapeutic mechanism of Paederia scandens against nonalcoholic fatty liver disease in chicken

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Wu, Qiang, Yang, Fan, Tang, Huaqiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046938/ https://www.ncbi.nlm.nih.gov/pubmed/33810823 http://dx.doi.org/10.1016/j.psj.2021.101042

Ejemplares similares

Based on network pharmacology method to discovered the targets and therapeutic mechanism of Paederia scandens against nonalcoholic fatty liver disease in chicken
por: Wu, Qiang, et al.
Publicado: (2020)

The Anti-Oxidation and Mechanism of Essential Oil of Paederia scandens in the NAFLD Model of Chicken
por: Wu, Qiang, et al.
Publicado: (2019)

Feruloylmonotropeins: promising natural antioxidants in Paederia scandens
por: Trung, Nguyen Quang, et al.
Publicado: (2023)

Determination and Mechanism of Antidiarrheal Chemical Constituents of Paederia scandens Determined by HPLC-ESI-MS Integrated with Network Pharmacology
por: Ai, Liwen, et al.
Publicado: (2023)

Characterization of the complete chloroplast genome of Paederia scandens (Rubiaceae): a Chinese folk medicinal plant
por: Li, Zheng-Hui, et al.
Publicado: (2019)

Hepatoprotection of Paederia scandens (Lour.) Merr. on Acetaminophen-Related Hepatic Injury Rats by (1)H-NMR-Based Metabonomics Coupled with Network Pharmacology
por: Tang, Chao-Ling, et al.
Publicado: (2022)

Discovery and Characterization of a Novel Umbravirus from Paederia scandens Plants Showing Leaf Chlorosis and Yellowing Symptoms
por: Zheng, Lianshun, et al.
Publicado: (2022)

Corrigendum: Vegetarian diet, food substitution, and nonalcoholic fatty liver
Publicado: (2018)

Corrigendum to “Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease”
por: Masarone, Mario, et al.
Publicado: (2021)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
Publicado: (2023)

Ultrasonic-assisted extraction of polyphenolic compounds from Paederia scandens (Lour.) Merr. Using deep eutectic solvent: optimization, identification, and comparison with traditional methods
por: Liu, Yuxin, et al.
Publicado: (2022)

Corrigendum to “Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives”
por: Gitt, Stefano, et al.
Publicado: (2020)

Corrigenda: Table Correction. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
por: Lee, Yong-ho, et al.
Publicado: (2019)

Corrigendum to “The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease”
por: Lewis, John E., et al.
Publicado: (2020)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
Publicado: (2013)

Corrigendum to “Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice”
por: Lee, Yong-Jik, et al.
Publicado: (2019)

Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease
por: Jeznach-Steinhagen, Anna, et al.
Publicado: (2019)

Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182()
por: Kell, Douglas B, et al.
Publicado: (2014)

The Efficacy of Pharmacological Treatment in Pediatric Nonalcoholic Fatty Liver Disease
por: Cho, Taeshik, et al.
Publicado: (2012)

Antioxidant Activity and Phenolic Content of Paederia foetida and Syzygium aqueum
por: Osman, Hasnah, et al.
Publicado: (2009)

The complete chloroplast genome of the medicinal plant Paederia foetida L.
por: Wang, Wei, et al.
Publicado: (2022)

Complete chloroplast genome sequence of Ampelocalamus scandens (Arundinarodae)
por: Fan, Lili, et al.
Publicado: (2020)

Network Pharmacology-Based Investigation of the Therapeutic Mechanisms of Action of Danning Tablets in Nonalcoholic Fatty Liver Disease
por: Lin, Tong, et al.
Publicado: (2021)

Corrigendum to “Systematic Understanding of the Mechanism of Baicalin against Ischemic Stroke through a Network Pharmacology Approach”
por: Xu, Tian, et al.
Publicado: (2019)

Paederia foetida Linn. leaf extract: an antihyperlipidemic, antihyperglycaemic and antioxidant activity
por: Kumar, Vikas, et al.
Publicado: (2014)

Pharmacological Activities of Alisma orientale against Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: Literature Review
por: Choi, Eunsol, et al.
Publicado: (2019)

Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease
por: Durazzo, Marilena, et al.
Publicado: (2012)

Comparison of the effect of light alcohol consumption on Japanese men with and without fatty liver
por: Hara, Tasuku, et al.
Publicado: (2020)

Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans
por: Miyata, Tatsunori, et al.
Publicado: (2022)

Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology
por: Huang, Yuanshe, et al.
Publicado: (2022)

Corrigendum to “Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp”
por: Mahamid, Mahmud, et al.
Publicado: (2017)

Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy [Corrigendum]
Publicado: (2021)

Neuroprotective Effects of Melatonin and Celecoxib against Ethanol-Induced Neurodegeneration: A Computational and Pharmacological Approach [Corrigendum]
Publicado: (2023)

Functional connexin35 increased in the myopic chicken retina—CORRIGENDUM
por: Banerjee, Seema, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
por: Huang, Yue Ye, et al.
Publicado: (2013)

Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications
por: Andronescu, Craita Isabela, et al.
Publicado: (2018)

Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
por: Yu, Yao, et al.
Publicado: (2018)

Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
por: Mijangos-Trejo, Alejandra, et al.
Publicado: (2023)

Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease
por: Chen, Wei, et al.
Publicado: (2018)

Neuropharmacological properties of Mikania scandens (L.) Willd. (Asteraceae)
por: Dey, Protapaditya, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_83vsregkla4ul2u18q4ed665t7